Thomas G. Wiggans - Nov 21, 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role: Director
Signature: /s/ Herb Cross, as Attorney-in-Fact
Stock symbol: JSPR
Transactions as of: Nov 21, 2023
Transactions value $: $6,383
Form type: 4
Date filed: 11/22/2023, 04:06 PM
Previous filing: Nov 20, 2023
Next filing: Nov 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JSPR	Voting Common Stock	Purchase	$6.38K	+10K	+33.33%	$0.64	40K	Nov 21, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.63 to $0.65, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.63 to $0.65, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.